Long-Awaited Guidance on FDAMA 115: Confirmatory Evidence Finally Has Its Moment (to be Crossed Off the FDA’s Guidance To-Do List)
FDA Law Blog
OCTOBER 2, 2023
The eagerly anticipated guidance, Demonstrating Substantial Evidence of Effectiveness With One Adequate and Well-Controlled Clinical Investigation and Confirmatory Evidence (i.e., We are heartened to see that this latest guidance reflects many of the advances we observed in practice since 2019.
Let's personalize your content